No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception

Guilbert, Édith; Costescu, Dustin; Dunn, Sheila; Fisher, William A.; Kives, Sari; Mirosh, Melissa; Norman, Wendy V.; Pymar, Helen; Reid, Robert L.; Roy, Geneviève; Varto, Hannah; Waddington, Ashley; Wagner, Marie-Soleil; Whelan, Anne Marie

doi:10.1016/j.jogc.2016.10.005

Cited by 49 publications

(79 citation statements)

References 334 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most contraceptive methods can be initiated at any time during the menstrual cycle provided that pregnancy or the possibility of pregnancy can be ruled out (Table 3) (41,42).…”

Section: Starting Contraceptionmentioning

confidence: 99%

“…Adolescents who choose to Quick Start contraception when a very early pregnancy cannot be completely excluded can be reassured that current evidence does not demonstrate an adverse impact of contraceptive hormone exposure on either fetal development or pregnancy outcomes (45,46). When using the Quick Start method, back-up contraception (barrier method and/or abstinence) should be used for the first seven consecutive days of contraceptive use unless it is initiated on the first day of menses (42). Adolescents may choose to start hormonal contraception on the first day of the next menstrual cycle or do a "Sunday start".…”

Section: Starting Contraceptionmentioning

confidence: 99%

“…There are no contraindications to CHC use based on body weight and/or BMI alone (17,42). Studies demonstrate either equivalent or increased pregnancy rates among obese CHC users, however more high quality studies are needed (88).…”

Section: Obesitymentioning

confidence: 99%

“…At no time should the HFI exceed seven days. The ring can stay in the vagina during sexual intercourse but if the adolescent does wish to remove it during intercourse, it should not remain out of the vagina for more than three hours(42). Data on CHC effect on mood is conflicting.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Contraception for Adolescents

Todd¹,

Black²

2020

Jcrpe

Self Cite

View full text Add to dashboard Cite

Although pregnancy and abortion rates have declined in adolescents, unintended pregnancies remain unacceptably high in this age group. The use of highly effective methods of contraception is one of the pillars of unintended pregnancy prevention and requires a shared decision making process within a rights based framework. Adolescents are eligible to use any method of contraception and long-acting reversible contraceptives, which are "forgettable" and highly effective, may be particularly suited for many adolescents. Contraceptive methods may have additional non-contraceptive benefits that address other needs or concerns of the adolescent. Dual method use should be encouraged among adolescents for the prevention of both unintended pregnancies and sexually transmitted infections. Health care providers have an important role to play in ensuring that adolescents have access to high quality and non-judgmental reproductive health care services and contraceptive methods in adolescent-friendly settings that recognize the unique biopsychosocial needs of the adolescent. Abstract 28

show abstract

“…Most contraceptive methods can be initiated at any time during the menstrual cycle provided that pregnancy or the possibility of pregnancy can be ruled out (Table 3) (41,42).…”

Section: Starting Contraceptionmentioning

confidence: 99%

Section: Starting Contraceptionmentioning

confidence: 99%

Section: Obesitymentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Contraception for Adolescents

Todd¹,

Black²

2020

Jcrpe

Self Cite

View full text Add to dashboard Cite

show abstract

“…Further examination can be delayed until a later visit. Prior to initiating hormonal treatment, only blood pressure must be documented (15). HCP should explain the steps and elicit frequent feedback.…”

Section: Physical Examinationmentioning

confidence: 99%

Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents

Sachedina¹,

Todd²

2020

Jcrpe

View full text Add to dashboard Cite

Most adolescents will experience discomfort during menstruation. Due to normalization of dysmenorrhea, there is delay to diagnosis and treatment. Non-steroidal anti-inflammatories are a first line treatment. Adolescents can safely be offered menstrual suppression with combined hormonal contraception, and progestin-only options. When the above are ineffective, gonadotropin releasing hormone agonists with add back treatment can be considered. Transabdominal ultrasound is indicated when first line treatments do not improve symptoms. Endometriosis should be considered in adolescents who experience ongoing pain despite medical treatment. If laparoscopy is performed and endometriosis visualized, it should be treated with either excision or ablation. Women with endometriosis should be counselled on menstrual suppression until fertility is desired. Management of chronic pain requires the involvement of a multidisciplinary team.

show abstract

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

McAuliffe

Killeen

Jacob

et al. 2020

Intl J Gynecology & Obste

114

View full text Add to dashboard Cite

Obstetricians and gynecologists are well positioned to influence population health through maternity and women's health services. Obesity is common in women of reproductive age and the prevalence is rising in both low-/middle-income and high-income countries 1. Obesity affects requirements for assessment, monitoring, and intervention and can impact maternal and child outcomes. Obstetricians and gynecologists require guidance on the care of women of reproductive age with obesity at all time points related to pregnancy, including how to address modifiable risk factors such as diet and physical activity. Many guidelines have been developed to date, although they vary in scope, methodology, and individual recommendations. FIGO's Committee Guideline for the Management of Prepregnancy, Pregnancy, and Postpartum Obesity (Table 1) reviews good clinical practice recommendations (Table 2-4) from previously published international documents. It serves as a practical resource to support obstetricians and gynecologists in the management of This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception

Cited by 49 publications

References 334 publications

Contraception for Adolescents

Contraception for Adolescents

Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

Contact Info

Product

Resources

About